| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Charcot-Marie-Tooth Disease | 45 | 2026 | 238 | 9.040 |
Why?
|
| Schwann Cells | 15 | 2024 | 62 | 2.010 |
Why?
|
| Mutation | 45 | 2026 | 6194 | 1.900 |
Why?
|
| Myelin Sheath | 8 | 2024 | 128 | 1.750 |
Why?
|
| Axons | 15 | 2024 | 384 | 1.630 |
Why?
|
| Connexins | 13 | 2023 | 64 | 1.390 |
Why?
|
| Pharmacogenetics | 8 | 2025 | 203 | 1.250 |
Why?
|
| Peripheral Nervous System Diseases | 8 | 2024 | 137 | 1.110 |
Why?
|
| Neurofilament Proteins | 3 | 2018 | 39 | 0.920 |
Why?
|
| Research Personnel | 2 | 2024 | 139 | 0.800 |
Why?
|
| High-Throughput Nucleotide Sequencing | 10 | 2025 | 934 | 0.770 |
Why?
|
| Nerve Fibers, Myelinated | 4 | 2018 | 84 | 0.760 |
Why?
|
| Intermediate Filaments | 2 | 2020 | 11 | 0.730 |
Why?
|
| Sequence Analysis, DNA | 23 | 2023 | 1746 | 0.720 |
Why?
|
| Guillain-Barre Syndrome | 3 | 2024 | 33 | 0.670 |
Why?
|
| Gap Junctions | 3 | 2011 | 43 | 0.660 |
Why?
|
| Demyelinating Diseases | 6 | 2025 | 68 | 0.660 |
Why?
|
| Nervous System Diseases | 5 | 2024 | 403 | 0.650 |
Why?
|
| Tripartite Motif Proteins | 1 | 2020 | 24 | 0.640 |
Why?
|
| Nerve Tissue Proteins | 7 | 2022 | 1130 | 0.630 |
Why?
|
| Optic Nerve | 1 | 2021 | 115 | 0.630 |
Why?
|
| Optic Nerve Diseases | 1 | 2021 | 80 | 0.620 |
Why?
|
| Humans | 137 | 2026 | 131781 | 0.610 |
Why?
|
| Genes, Dominant | 7 | 2020 | 252 | 0.600 |
Why?
|
| Genotype | 20 | 2025 | 2655 | 0.590 |
Why?
|
| Phenotype | 22 | 2025 | 4528 | 0.580 |
Why?
|
| Thyroid Carcinoma, Anaplastic | 3 | 2024 | 19 | 0.560 |
Why?
|
| Cytochrome P-450 CYP2D6 | 4 | 2025 | 34 | 0.550 |
Why?
|
| Microfilament Proteins | 3 | 2017 | 272 | 0.550 |
Why?
|
| Candida albicans | 7 | 2000 | 88 | 0.550 |
Why?
|
| Pedigree | 19 | 2025 | 1712 | 0.540 |
Why?
|
| Neural Conduction | 9 | 2024 | 83 | 0.540 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 363 | 0.520 |
Why?
|
| Ranvier's Nodes | 5 | 2017 | 74 | 0.510 |
Why?
|
| Potassium Channels, Voltage-Gated | 3 | 2001 | 63 | 0.510 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2019 | 3416 | 0.510 |
Why?
|
| Disease Models, Animal | 10 | 2024 | 4684 | 0.490 |
Why?
|
| Tomography, Optical Coherence | 1 | 2021 | 463 | 0.490 |
Why?
|
| Animals | 54 | 2024 | 34402 | 0.490 |
Why?
|
| Neuroglia | 3 | 2008 | 223 | 0.480 |
Why?
|
| Polymorphism, Single Nucleotide | 12 | 2023 | 2859 | 0.470 |
Why?
|
| Mutation, Missense | 8 | 2025 | 932 | 0.460 |
Why?
|
| Genetic Testing | 9 | 2024 | 1101 | 0.460 |
Why?
|
| Thyroid Neoplasms | 3 | 2024 | 248 | 0.460 |
Why?
|
| Middle Aged | 51 | 2025 | 28897 | 0.450 |
Why?
|
| Young Adult | 29 | 2025 | 10102 | 0.450 |
Why?
|
| Male | 76 | 2025 | 65290 | 0.450 |
Why?
|
| Peripheral Nervous System | 4 | 2024 | 46 | 0.440 |
Why?
|
| Female | 72 | 2026 | 71221 | 0.430 |
Why?
|
| Alleles | 13 | 2023 | 1711 | 0.430 |
Why?
|
| Adult | 51 | 2025 | 31710 | 0.420 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 3 | 2018 | 35 | 0.410 |
Why?
|
| Pharmacogenomic Testing | 3 | 2025 | 47 | 0.410 |
Why?
|
| Transcription Factors | 4 | 2021 | 2438 | 0.400 |
Why?
|
| Sciatic Nerve | 9 | 2005 | 59 | 0.390 |
Why?
|
| Myelin Proteins | 7 | 2024 | 78 | 0.380 |
Why?
|
| Peripheral Nerves | 9 | 2017 | 89 | 0.380 |
Why?
|
| Antigens, Viral | 1 | 2014 | 395 | 0.380 |
Why?
|
| Evolution, Molecular | 13 | 2015 | 657 | 0.380 |
Why?
|
| Mice | 27 | 2023 | 18479 | 0.370 |
Why?
|
| Polyneuropathies | 3 | 2017 | 31 | 0.370 |
Why?
|
| Genetic Variation | 10 | 2020 | 1562 | 0.370 |
Why?
|
| Cytomegalovirus Infections | 1 | 2014 | 225 | 0.360 |
Why?
|
| Chromosome Mapping | 15 | 2018 | 1069 | 0.360 |
Why?
|
| Connexin 43 | 2 | 2011 | 34 | 0.360 |
Why?
|
| Cell Adhesion Molecules | 5 | 2018 | 227 | 0.360 |
Why?
|
| Antihypertensive Agents | 4 | 2018 | 422 | 0.350 |
Why?
|
| Genes, Modifier | 3 | 2024 | 15 | 0.350 |
Why?
|
| Membrane Proteins | 6 | 2012 | 1610 | 0.350 |
Why?
|
| Cytochrome P-450 CYP2A6 | 3 | 2022 | 11 | 0.350 |
Why?
|
| Genomics | 10 | 2025 | 1626 | 0.350 |
Why?
|
| Disease Progression | 7 | 2025 | 2221 | 0.340 |
Why?
|
| Aged | 27 | 2025 | 21263 | 0.330 |
Why?
|
| GTP Phosphohydrolases | 4 | 2020 | 159 | 0.330 |
Why?
|
| Genes, Fungal | 5 | 2000 | 60 | 0.330 |
Why?
|
| Astrocytes | 2 | 2011 | 288 | 0.320 |
Why?
|
| Severity of Illness Index | 10 | 2025 | 3094 | 0.320 |
Why?
|
| Oligodendroglia | 5 | 2020 | 80 | 0.320 |
Why?
|
| Mitochondrial Proteins | 4 | 2020 | 276 | 0.310 |
Why?
|
| Urinary Bladder Neoplasms | 6 | 2019 | 545 | 0.300 |
Why?
|
| Cell Membrane | 4 | 2008 | 464 | 0.300 |
Why?
|
| Blood Pressure | 4 | 2018 | 1344 | 0.290 |
Why?
|
| L-Iditol 2-Dehydrogenase | 2 | 2025 | 2 | 0.290 |
Why?
|
| Base Sequence | 20 | 2022 | 2783 | 0.290 |
Why?
|
| Neurons | 5 | 2020 | 1995 | 0.290 |
Why?
|
| Spinal Cord | 3 | 2013 | 269 | 0.290 |
Why?
|
| Adolescent | 28 | 2025 | 20994 | 0.280 |
Why?
|
| Scoliosis | 2 | 2023 | 145 | 0.280 |
Why?
|
| Nicotine | 2 | 2020 | 117 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 12 | 2 | 2006 | 92 | 0.280 |
Why?
|
| Motor Neurons | 2 | 2020 | 138 | 0.280 |
Why?
|
| Kidney Transplantation | 4 | 2017 | 572 | 0.270 |
Why?
|
| Genome | 6 | 2014 | 473 | 0.270 |
Why?
|
| Myelin P0 Protein | 5 | 2022 | 28 | 0.270 |
Why?
|
| Nervous System | 1 | 2008 | 123 | 0.260 |
Why?
|
| Pharmacogenomic Variants | 2 | 2018 | 39 | 0.260 |
Why?
|
| Molecular Sequence Data | 18 | 2013 | 3616 | 0.260 |
Why?
|
| Hydrochlorothiazide | 2 | 2018 | 67 | 0.260 |
Why?
|
| Rats | 16 | 2024 | 3460 | 0.260 |
Why?
|
| Fungal Proteins | 3 | 1998 | 132 | 0.260 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 2 | 2004 | 38 | 0.260 |
Why?
|
| Cytoskeletal Proteins | 5 | 2001 | 279 | 0.260 |
Why?
|
| Computational Biology | 3 | 2024 | 872 | 0.250 |
Why?
|
| Cell Communication | 6 | 2017 | 195 | 0.250 |
Why?
|
| Potassium Channels | 3 | 2001 | 156 | 0.240 |
Why?
|
| Hypertension | 4 | 2018 | 1360 | 0.240 |
Why?
|
| Cytochrome P-450 CYP2C19 | 2 | 2025 | 27 | 0.240 |
Why?
|
| Protein Prenylation | 1 | 2005 | 8 | 0.230 |
Why?
|
| Genes, Insect | 3 | 2015 | 113 | 0.230 |
Why?
|
| DNA Mutational Analysis | 7 | 2016 | 803 | 0.230 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2025 | 19 | 0.230 |
Why?
|
| Phylogeny | 7 | 2015 | 710 | 0.220 |
Why?
|
| Genetic Association Studies | 5 | 2023 | 838 | 0.220 |
Why?
|
| Phosphoproteins | 4 | 2017 | 430 | 0.220 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2025 | 34 | 0.220 |
Why?
|
| Smoking Cessation | 2 | 2024 | 190 | 0.220 |
Why?
|
| Cell Differentiation | 3 | 2008 | 1948 | 0.220 |
Why?
|
| TRPV Cation Channels | 1 | 2025 | 47 | 0.220 |
Why?
|
| Aged, 80 and over | 11 | 2020 | 6916 | 0.220 |
Why?
|
| Synteny | 4 | 2015 | 69 | 0.210 |
Why?
|
| Exons | 6 | 2022 | 769 | 0.210 |
Why?
|
| Mice, Transgenic | 8 | 2020 | 2363 | 0.210 |
Why?
|
| Graft Survival | 4 | 2017 | 466 | 0.210 |
Why?
|
| Cost of Illness | 2 | 2024 | 291 | 0.210 |
Why?
|
| Genome, Human | 6 | 2019 | 1331 | 0.210 |
Why?
|
| Nicotinic Agonists | 1 | 2024 | 33 | 0.210 |
Why?
|
| Mice, Knockout | 6 | 2022 | 3862 | 0.210 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 1 | 2003 | 12 | 0.200 |
Why?
|
| Psychodidae | 1 | 2023 | 12 | 0.200 |
Why?
|
| Exome | 5 | 2016 | 1076 | 0.200 |
Why?
|
| Neurosciences | 1 | 2023 | 48 | 0.200 |
Why?
|
| Phlebotomus | 1 | 2023 | 14 | 0.200 |
Why?
|
| HLA-B Antigens | 3 | 2008 | 30 | 0.200 |
Why?
|
| Isaacs Syndrome | 1 | 2022 | 1 | 0.190 |
Why?
|
| Leishmania | 1 | 2023 | 33 | 0.190 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2023 | 49 | 0.190 |
Why?
|
| Ring Chromosomes | 1 | 2022 | 12 | 0.190 |
Why?
|
| Nephritis, Hereditary | 1 | 2022 | 21 | 0.190 |
Why?
|
| Adenocarcinoma | 2 | 2024 | 999 | 0.190 |
Why?
|
| Cytochrome P-450 CYP2C8 | 1 | 2022 | 3 | 0.180 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2024 | 221 | 0.180 |
Why?
|
| Cytochrome P-450 CYP2C9 | 1 | 2022 | 7 | 0.180 |
Why?
|
| Hematuria | 1 | 2022 | 48 | 0.180 |
Why?
|
| Neurology | 1 | 2024 | 120 | 0.180 |
Why?
|
| Gene Expression Profiling | 5 | 2018 | 1835 | 0.180 |
Why?
|
| Karyotyping | 3 | 2022 | 313 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 4 | 2018 | 4767 | 0.180 |
Why?
|
| Child | 20 | 2025 | 26316 | 0.180 |
Why?
|
| Hearing Loss | 2 | 2015 | 210 | 0.180 |
Why?
|
| Chromosomes, Fungal | 4 | 2000 | 49 | 0.180 |
Why?
|
| Nerve Growth Factors | 2 | 2017 | 69 | 0.180 |
Why?
|
| Axonal Transport | 1 | 2021 | 27 | 0.180 |
Why?
|
| Atenolol | 2 | 2018 | 44 | 0.180 |
Why?
|
| Microvilli | 1 | 2001 | 65 | 0.180 |
Why?
|
| Polymorphism, Genetic | 5 | 2018 | 794 | 0.170 |
Why?
|
| Vinblastine | 1 | 2021 | 55 | 0.170 |
Why?
|
| Nerve Fibers | 1 | 2021 | 69 | 0.170 |
Why?
|
| Nuclear Proteins | 4 | 2019 | 1226 | 0.170 |
Why?
|
| Diabetic Neuropathies | 1 | 2001 | 56 | 0.170 |
Why?
|
| Child, Preschool | 14 | 2025 | 15057 | 0.170 |
Why?
|
| Blood Proteins | 1 | 2001 | 140 | 0.170 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 117 | 0.160 |
Why?
|
| Cross-Sectional Studies | 7 | 2025 | 3838 | 0.160 |
Why?
|
| Endometrial Neoplasms | 2 | 2012 | 110 | 0.160 |
Why?
|
| Sural Nerve | 4 | 2016 | 46 | 0.160 |
Why?
|
| Mosaicism | 1 | 2022 | 249 | 0.160 |
Why?
|
| Cytochrome P-450 CYP2B6 | 1 | 2020 | 15 | 0.160 |
Why?
|
| Action Potentials | 3 | 2017 | 470 | 0.160 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2020 | 20 | 0.160 |
Why?
|
| Transcriptome | 3 | 2017 | 1150 | 0.160 |
Why?
|
| Urothelium | 2 | 2019 | 61 | 0.160 |
Why?
|
| Tubulin | 1 | 2020 | 75 | 0.160 |
Why?
|
| Age of Onset | 4 | 2020 | 631 | 0.160 |
Why?
|
| Base Composition | 5 | 2015 | 73 | 0.160 |
Why?
|
| Multigene Family | 2 | 2014 | 290 | 0.160 |
Why?
|
| HeLa Cells | 4 | 2013 | 694 | 0.160 |
Why?
|
| DNA | 3 | 2006 | 1440 | 0.150 |
Why?
|
| Patch-Clamp Techniques | 4 | 2017 | 279 | 0.150 |
Why?
|
| Amino Acid Sequence | 10 | 2018 | 2565 | 0.150 |
Why?
|
| Forkhead Transcription Factors | 2 | 2024 | 372 | 0.150 |
Why?
|
| DNA Polymerase gamma | 1 | 2019 | 17 | 0.150 |
Why?
|
| Autopsy | 2 | 2016 | 119 | 0.150 |
Why?
|
| Protein Structure, Tertiary | 3 | 2011 | 723 | 0.150 |
Why?
|
| RNA, Messenger | 10 | 2022 | 2570 | 0.150 |
Why?
|
| Silver-Russell Syndrome | 1 | 2019 | 2 | 0.150 |
Why?
|
| Genetic Markers | 6 | 2020 | 605 | 0.150 |
Why?
|
| Heterozygote | 4 | 2022 | 728 | 0.150 |
Why?
|
| Smoking | 2 | 2024 | 927 | 0.150 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2012 | 200 | 0.150 |
Why?
|
| Bestrophins | 1 | 2018 | 14 | 0.150 |
Why?
|
| Clinical Protocols | 1 | 2020 | 228 | 0.150 |
Why?
|
| Clonal Evolution | 1 | 2019 | 49 | 0.150 |
Why?
|
| Immunohistochemistry | 5 | 2010 | 1610 | 0.140 |
Why?
|
| COS Cells | 3 | 2008 | 249 | 0.140 |
Why?
|
| Foot | 1 | 2019 | 62 | 0.140 |
Why?
|
| GTPase-Activating Proteins | 1 | 2019 | 86 | 0.140 |
Why?
|
| Facies | 1 | 2019 | 157 | 0.140 |
Why?
|
| Retinoblastoma Protein | 3 | 2008 | 78 | 0.140 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 2 | 2010 | 19 | 0.140 |
Why?
|
| Repressor Proteins | 2 | 2024 | 781 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1998 | 77 | 0.140 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 1140 | 0.140 |
Why?
|
| Muscle Weakness | 1 | 2019 | 90 | 0.140 |
Why?
|
| HLA-A Antigens | 2 | 2008 | 33 | 0.140 |
Why?
|
| Carcinogenesis | 2 | 2019 | 357 | 0.140 |
Why?
|
| Renin | 1 | 2018 | 76 | 0.140 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2017 | 7 | 0.140 |
Why?
|
| Visual Acuity | 1 | 2021 | 535 | 0.140 |
Why?
|
| Brain | 4 | 2014 | 3236 | 0.140 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 9 | 2008 | 351 | 0.140 |
Why?
|
| Erythropoietin | 1 | 1998 | 105 | 0.140 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2018 | 65 | 0.140 |
Why?
|
| Autoantibodies | 2 | 2017 | 466 | 0.130 |
Why?
|
| Median Nerve | 1 | 2017 | 12 | 0.130 |
Why?
|
| Registries | 1 | 2025 | 1598 | 0.130 |
Why?
|
| Genes | 3 | 2006 | 308 | 0.130 |
Why?
|
| Mice, Mutant Strains | 1 | 2018 | 366 | 0.130 |
Why?
|
| Expressed Sequence Tags | 5 | 2006 | 80 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 4 | 2017 | 1219 | 0.130 |
Why?
|
| Foot Deformities, Congenital | 1 | 2017 | 16 | 0.130 |
Why?
|
| Models, Theoretical | 1 | 2020 | 366 | 0.130 |
Why?
|
| Carpal Tunnel Syndrome | 1 | 2017 | 20 | 0.130 |
Why?
|
| Skin | 2 | 2017 | 553 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2017 | 11 | 0.130 |
Why?
|
| Kv1.2 Potassium Channel | 3 | 2001 | 18 | 0.130 |
Why?
|
| Longitudinal Studies | 4 | 2023 | 1518 | 0.130 |
Why?
|
| Ankle | 1 | 2017 | 29 | 0.130 |
Why?
|
| Kv1.1 Potassium Channel | 3 | 2001 | 39 | 0.130 |
Why?
|
| Cardiomyopathies | 2 | 2016 | 517 | 0.130 |
Why?
|
| Chlorthalidone | 1 | 2017 | 25 | 0.130 |
Why?
|
| Software | 2 | 2018 | 752 | 0.130 |
Why?
|
| Internet | 2 | 2018 | 423 | 0.130 |
Why?
|
| Neprilysin | 1 | 2016 | 20 | 0.130 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 618 | 0.130 |
Why?
|
| Transfection | 3 | 2017 | 960 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 2 | 2013 | 646 | 0.120 |
Why?
|
| Mutant Proteins | 1 | 2017 | 113 | 0.120 |
Why?
|
| Psychometrics | 1 | 2020 | 677 | 0.120 |
Why?
|
| Carcinoma | 1 | 2019 | 283 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 2004 | 0.120 |
Why?
|
| Myelin P2 Protein | 1 | 2016 | 10 | 0.120 |
Why?
|
| Animals, Newborn | 3 | 2011 | 1023 | 0.120 |
Why?
|
| Orthopedic Procedures | 1 | 2017 | 76 | 0.120 |
Why?
|
| Actins | 2 | 2009 | 317 | 0.120 |
Why?
|
| Death, Sudden | 1 | 2016 | 44 | 0.120 |
Why?
|
| Cholesterol, HDL | 2 | 2013 | 394 | 0.120 |
Why?
|
| Nerve Regeneration | 3 | 2001 | 76 | 0.120 |
Why?
|
| Lymphatic Diseases | 1 | 1996 | 28 | 0.120 |
Why?
|
| Pseudomonas | 1 | 2015 | 14 | 0.120 |
Why?
|
| Aortic Aneurysm, Thoracic | 4 | 2009 | 699 | 0.120 |
Why?
|
| DNA Methylation | 3 | 2019 | 1088 | 0.120 |
Why?
|
| Receptors, KIR | 2 | 2013 | 11 | 0.120 |
Why?
|
| Muscle Proteins | 1 | 2018 | 404 | 0.120 |
Why?
|
| Linkage Disequilibrium | 3 | 2018 | 318 | 0.120 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 2353 | 0.120 |
Why?
|
| Cells, Cultured | 8 | 2011 | 2968 | 0.120 |
Why?
|
| Alanine-tRNA Ligase | 1 | 2015 | 2 | 0.120 |
Why?
|
| Residence Characteristics | 1 | 2018 | 293 | 0.120 |
Why?
|
| Mobility Limitation | 1 | 2015 | 35 | 0.110 |
Why?
|
| Sorbitol | 2 | 2025 | 8 | 0.110 |
Why?
|
| Drosophila melanogaster | 3 | 2014 | 846 | 0.110 |
Why?
|
| Milk | 1 | 2015 | 108 | 0.110 |
Why?
|
| United States | 4 | 2024 | 11815 | 0.110 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 3694 | 0.110 |
Why?
|
| Family Health | 3 | 2016 | 251 | 0.110 |
Why?
|
| Arthropods | 1 | 2014 | 22 | 0.110 |
Why?
|
| Bees | 1 | 2015 | 52 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2006 | 91 | 0.110 |
Why?
|
| Pelizaeus-Merzbacher Disease | 1 | 2014 | 22 | 0.110 |
Why?
|
| Macrophages | 1 | 2018 | 661 | 0.110 |
Why?
|
| Sequence Alignment | 6 | 2013 | 595 | 0.110 |
Why?
|
| DNA Copy Number Variations | 2 | 2018 | 1023 | 0.110 |
Why?
|
| Motor Neuron Disease | 2 | 2013 | 16 | 0.110 |
Why?
|
| Cloning, Molecular | 5 | 2001 | 786 | 0.110 |
Why?
|
| Antibody Specificity | 2 | 2007 | 201 | 0.100 |
Why?
|
| Bulbar Palsy, Progressive | 1 | 2013 | 7 | 0.100 |
Why?
|
| Membrane Potentials | 2 | 2014 | 297 | 0.100 |
Why?
|
| Argininosuccinate Lyase | 1 | 1994 | 62 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 2 | 2014 | 382 | 0.100 |
Why?
|
| Molecular Sequence Annotation | 1 | 2014 | 152 | 0.100 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2015 | 358 | 0.100 |
Why?
|
| Neutropenia | 1 | 1995 | 205 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2013 | 299 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2010 | 625 | 0.100 |
Why?
|
| Myocytes, Cardiac | 2 | 2011 | 673 | 0.100 |
Why?
|
| Social Behavior | 1 | 2015 | 217 | 0.100 |
Why?
|
| Chromosome Breakage | 3 | 2008 | 156 | 0.100 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 1617 | 0.100 |
Why?
|
| Genes, X-Linked | 1 | 2013 | 60 | 0.100 |
Why?
|
| Apolipoproteins A | 1 | 2013 | 53 | 0.100 |
Why?
|
| Haplotypes | 5 | 2022 | 550 | 0.100 |
Why?
|
| DNA Transposable Elements | 4 | 2008 | 182 | 0.100 |
Why?
|
| Sensory Receptor Cells | 1 | 2013 | 61 | 0.100 |
Why?
|
| Angiotensin II | 2 | 2018 | 135 | 0.100 |
Why?
|
| Fenofibrate | 1 | 2013 | 59 | 0.100 |
Why?
|
| Carcinoma in Situ | 1 | 2013 | 72 | 0.100 |
Why?
|
| Correction of Hearing Impairment | 1 | 2012 | 1 | 0.100 |
Why?
|
| Abnormalities, Multiple | 1 | 2019 | 974 | 0.100 |
Why?
|
| Spiral Ganglion | 1 | 2012 | 10 | 0.100 |
Why?
|
| Cohort Studies | 6 | 2020 | 5122 | 0.100 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2019 | 621 | 0.090 |
Why?
|
| Gene Rearrangement | 5 | 2015 | 323 | 0.090 |
Why?
|
| Genome, Insect | 2 | 2014 | 81 | 0.090 |
Why?
|
| Neurologic Examination | 3 | 2020 | 197 | 0.090 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2011 | 108 | 0.090 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2013 | 115 | 0.090 |
Why?
|
| Behavior, Animal | 1 | 2015 | 510 | 0.090 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2013 | 155 | 0.090 |
Why?
|
| Infant | 6 | 2025 | 13324 | 0.090 |
Why?
|
| Oncogenes | 1 | 2012 | 164 | 0.090 |
Why?
|
| Mutant Chimeric Proteins | 2 | 2008 | 15 | 0.090 |
Why?
|
| Ambulatory Care Facilities | 2 | 2024 | 236 | 0.090 |
Why?
|
| Hemostasis | 1 | 2012 | 73 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 1811 | 0.090 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2011 | 7 | 0.090 |
Why?
|
| Cochlear Implantation | 1 | 2012 | 57 | 0.090 |
Why?
|
| Spectral Karyotyping | 1 | 2011 | 8 | 0.090 |
Why?
|
| Receptors, Cell Surface | 3 | 2002 | 432 | 0.090 |
Why?
|
| Cochlear Implants | 1 | 2012 | 61 | 0.090 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 2 | 2001 | 82 | 0.090 |
Why?
|
| Time Factors | 6 | 2020 | 6279 | 0.090 |
Why?
|
| Xenopus | 1 | 2011 | 103 | 0.090 |
Why?
|
| Biophysics | 1 | 2011 | 49 | 0.080 |
Why?
|
| Gene Frequency | 3 | 2022 | 750 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 667 | 0.080 |
Why?
|
| Desmosomes | 2 | 2010 | 10 | 0.080 |
Why?
|
| Contig Mapping | 4 | 2006 | 51 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 191 | 0.080 |
Why?
|
| HLA-DQ Antigens | 2 | 2007 | 27 | 0.080 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2013 | 259 | 0.080 |
Why?
|
| Coculture Techniques | 1 | 2011 | 232 | 0.080 |
Why?
|
| Ankyrins | 2 | 2001 | 96 | 0.080 |
Why?
|
| Renal Insufficiency | 1 | 2013 | 252 | 0.080 |
Why?
|
| Genome-Wide Association Study | 4 | 2019 | 1844 | 0.080 |
Why?
|
| CpG Islands | 3 | 2006 | 339 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2024 | 1146 | 0.080 |
Why?
|
| Electric Stimulation | 1 | 2011 | 249 | 0.080 |
Why?
|
| Venous Thrombosis | 1 | 2012 | 168 | 0.080 |
Why?
|
| Dyslipidemias | 1 | 2013 | 247 | 0.080 |
Why?
|
| Serine | 2 | 2013 | 163 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2009 | 134 | 0.080 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2011 | 254 | 0.080 |
Why?
|
| Chromosomes, Human, X | 2 | 2013 | 155 | 0.080 |
Why?
|
| HLA Antigens | 2 | 2007 | 229 | 0.080 |
Why?
|
| Gene Duplication | 3 | 2006 | 364 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2011 | 344 | 0.080 |
Why?
|
| Family | 3 | 2018 | 593 | 0.080 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2010 | 80 | 0.080 |
Why?
|
| Access to Information | 1 | 2009 | 45 | 0.080 |
Why?
|
| Cation Transport Proteins | 1 | 2010 | 102 | 0.080 |
Why?
|
| Precision Medicine | 2 | 2025 | 378 | 0.080 |
Why?
|
| HLA-C Antigens | 1 | 2009 | 11 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 300 | 0.080 |
Why?
|
| Pan troglodytes | 2 | 2006 | 74 | 0.070 |
Why?
|
| Adenosine Triphosphatases | 1 | 2010 | 188 | 0.070 |
Why?
|
| DNA, Fungal | 3 | 1998 | 77 | 0.070 |
Why?
|
| Prospective Studies | 4 | 2023 | 6509 | 0.070 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 10 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2024 | 2993 | 0.070 |
Why?
|
| Melanoma | 1 | 1996 | 921 | 0.070 |
Why?
|
| Microsatellite Repeats | 2 | 2008 | 232 | 0.070 |
Why?
|
| Moyamoya Disease | 1 | 2009 | 42 | 0.070 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2008 | 31 | 0.070 |
Why?
|
| Physical Chromosome Mapping | 4 | 2002 | 55 | 0.070 |
Why?
|
| Glutamic Acid | 1 | 2009 | 209 | 0.070 |
Why?
|
| Tribolium | 1 | 2008 | 4 | 0.070 |
Why?
|
| Genes, Neoplasm | 1 | 2008 | 80 | 0.070 |
Why?
|
| Chromosome Inversion | 3 | 2006 | 73 | 0.070 |
Why?
|
| Guidelines as Topic | 1 | 2009 | 200 | 0.070 |
Why?
|
| Publishing | 1 | 2009 | 107 | 0.070 |
Why?
|
| Ornithine Carbamoyltransferase | 1 | 1988 | 23 | 0.070 |
Why?
|
| Conserved Sequence | 2 | 2005 | 282 | 0.070 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2007 | 39 | 0.070 |
Why?
|
| Research | 1 | 2009 | 269 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2011 | 468 | 0.070 |
Why?
|
| Models, Molecular | 5 | 2010 | 1087 | 0.070 |
Why?
|
| Genotyping Techniques | 2 | 2018 | 110 | 0.070 |
Why?
|
| Apoptosis | 3 | 2021 | 1860 | 0.070 |
Why?
|
| Tissue Distribution | 2 | 2005 | 366 | 0.070 |
Why?
|
| Myosin Heavy Chains | 1 | 2007 | 74 | 0.060 |
Why?
|
| Central Nervous System | 2 | 2017 | 286 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 1 | 2013 | 732 | 0.060 |
Why?
|
| In Vitro Techniques | 2 | 2019 | 824 | 0.060 |
Why?
|
| Hominidae | 1 | 2006 | 27 | 0.060 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2008 | 180 | 0.060 |
Why?
|
| Desmoplakins | 1 | 2006 | 12 | 0.060 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2006 | 18 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 3 | 2006 | 1489 | 0.060 |
Why?
|
| Sequence Deletion | 2 | 2006 | 514 | 0.060 |
Why?
|
| Neoplasms | 1 | 2021 | 2963 | 0.060 |
Why?
|
| Threonine | 1 | 2006 | 62 | 0.060 |
Why?
|
| Introns | 3 | 2017 | 288 | 0.060 |
Why?
|
| Femoral Nerve | 1 | 2005 | 6 | 0.060 |
Why?
|
| Codon, Terminator | 1 | 2005 | 27 | 0.060 |
Why?
|
| Food, Genetically Modified | 1 | 2005 | 4 | 0.060 |
Why?
|
| Vascular Diseases | 1 | 2007 | 155 | 0.060 |
Why?
|
| Methionine | 1 | 2006 | 96 | 0.060 |
Why?
|
| Patient Selection | 2 | 2024 | 726 | 0.060 |
Why?
|
| HLA-DR Antigens | 1 | 2005 | 70 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2007 | 323 | 0.060 |
Why?
|
| Biological Evolution | 1 | 2006 | 230 | 0.060 |
Why?
|
| Tissue Donors | 1 | 2009 | 502 | 0.060 |
Why?
|
| Allografts | 2 | 2017 | 209 | 0.060 |
Why?
|
| Mutagenesis, Insertional | 1 | 2006 | 152 | 0.060 |
Why?
|
| Selenoproteins | 2 | 2015 | 13 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2006 | 150 | 0.060 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 194 | 0.060 |
Why?
|
| Biotechnology | 1 | 2005 | 59 | 0.060 |
Why?
|
| Myelin-Associated Glycoprotein | 2 | 2001 | 6 | 0.060 |
Why?
|
| Cysteine | 1 | 2005 | 140 | 0.050 |
Why?
|
| Histocompatibility Testing | 3 | 2013 | 109 | 0.050 |
Why?
|
| Public Opinion | 1 | 2005 | 63 | 0.050 |
Why?
|
| Military Medicine | 1 | 2025 | 51 | 0.050 |
Why?
|
| Chromosomes | 1 | 2005 | 119 | 0.050 |
Why?
|
| Neuromuscular Diseases | 1 | 2025 | 48 | 0.050 |
Why?
|
| Rats, Inbred BN | 1 | 2004 | 16 | 0.050 |
Why?
|
| Glycine | 1 | 2005 | 166 | 0.050 |
Why?
|
| Microscopy, Electron | 2 | 2001 | 314 | 0.050 |
Why?
|
| Restriction Mapping | 2 | 1994 | 171 | 0.050 |
Why?
|
| Neurites | 2 | 2001 | 45 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2025 | 241 | 0.050 |
Why?
|
| Bupropion | 1 | 2024 | 27 | 0.050 |
Why?
|
| Italy | 1 | 2024 | 133 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2022 | 754 | 0.050 |
Why?
|
| Retrospective Studies | 5 | 2025 | 17667 | 0.050 |
Why?
|
| Neurologists | 1 | 2023 | 25 | 0.050 |
Why?
|
| Alternative Splicing | 3 | 2001 | 313 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2019 | 1912 | 0.050 |
Why?
|
| Factor Analysis, Statistical | 1 | 2024 | 235 | 0.050 |
Why?
|
| Databases, Genetic | 2 | 2016 | 500 | 0.050 |
Why?
|
| Euchromatin | 1 | 2002 | 12 | 0.050 |
Why?
|
| Peptides | 2 | 1998 | 835 | 0.050 |
Why?
|
| Lithuania | 1 | 2022 | 2 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2017 | 421 | 0.050 |
Why?
|
| Cell Line, Transformed | 2 | 2014 | 160 | 0.050 |
Why?
|
| Yeasts | 1 | 1982 | 42 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2000 | 405 | 0.050 |
Why?
|
| Operon | 1 | 1982 | 50 | 0.050 |
Why?
|
| Collagen Type IV | 1 | 2022 | 20 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2022 | 79 | 0.050 |
Why?
|
| Genetic Complementation Test | 2 | 2010 | 87 | 0.050 |
Why?
|
| Peripheral Nerve Injuries | 2 | 2001 | 37 | 0.050 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2022 | 28 | 0.050 |
Why?
|
| Vitamin K Epoxide Reductases | 1 | 2022 | 7 | 0.050 |
Why?
|
| Genomic Library | 2 | 2000 | 38 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2021 | 989 | 0.050 |
Why?
|
| Syndrome | 2 | 2019 | 1170 | 0.050 |
Why?
|
| Chronic Disease | 2 | 1997 | 1235 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 870 | 0.050 |
Why?
|
| Adherens Junctions | 1 | 2001 | 17 | 0.050 |
Why?
|
| Receptors, Odorant | 2 | 2014 | 36 | 0.050 |
Why?
|
| Carcinogenicity Tests | 1 | 2021 | 18 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2015 | 299 | 0.040 |
Why?
|
| Autoantigens | 1 | 2022 | 104 | 0.040 |
Why?
|
| Endosomes | 1 | 2022 | 72 | 0.040 |
Why?
|
| Cyclin D1 | 1 | 2002 | 109 | 0.040 |
Why?
|
| Human Genome Project | 3 | 2009 | 55 | 0.040 |
Why?
|
| Rats, Inbred BB | 1 | 2001 | 5 | 0.040 |
Why?
|
| Contactins | 1 | 2001 | 4 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2025 | 4053 | 0.040 |
Why?
|
| Aging | 3 | 2016 | 1265 | 0.040 |
Why?
|
| ras Proteins | 2 | 2013 | 146 | 0.040 |
Why?
|
| Prognosis | 2 | 2021 | 4953 | 0.040 |
Why?
|
| Actin Cytoskeleton | 1 | 2001 | 50 | 0.040 |
Why?
|
| Germ Cells | 1 | 2022 | 202 | 0.040 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2013 | 174 | 0.040 |
Why?
|
| Wheelchairs | 1 | 2020 | 18 | 0.040 |
Why?
|
| Rare Diseases | 1 | 2023 | 209 | 0.040 |
Why?
|
| Penetrance | 2 | 2016 | 117 | 0.040 |
Why?
|
| Stroke | 1 | 2009 | 1049 | 0.040 |
Why?
|
| Sodium Channels | 1 | 2001 | 99 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2001 | 102 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2001 | 109 | 0.040 |
Why?
|
| Orthotic Devices | 1 | 2020 | 20 | 0.040 |
Why?
|
| Cadherins | 1 | 2001 | 178 | 0.040 |
Why?
|
| Alaska | 1 | 2020 | 10 | 0.040 |
Why?
|
| Translocation, Genetic | 1 | 2022 | 350 | 0.040 |
Why?
|
| Cell Division | 1 | 2002 | 731 | 0.040 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2000 | 27 | 0.040 |
Why?
|
| Alaska Natives | 1 | 2020 | 5 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2000 | 68 | 0.040 |
Why?
|
| Lac Operon | 1 | 2000 | 89 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2009 | 5297 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 2001 | 169 | 0.040 |
Why?
|
| Drosophila | 1 | 2005 | 795 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2022 | 322 | 0.040 |
Why?
|
| Liver Transplantation | 1 | 2009 | 1133 | 0.040 |
Why?
|
| Basal Ganglia | 1 | 2020 | 60 | 0.040 |
Why?
|
| Genes, Recessive | 1 | 2020 | 201 | 0.040 |
Why?
|
| RNA Splice Sites | 2 | 2014 | 92 | 0.040 |
Why?
|
| Chromosomes, Artificial, Bacterial | 3 | 2008 | 90 | 0.040 |
Why?
|
| RNA, Untranslated | 2 | 2014 | 106 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2020 | 122 | 0.040 |
Why?
|
| Tangier Disease | 1 | 1999 | 6 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2022 | 577 | 0.040 |
Why?
|
| Indians, North American | 1 | 2020 | 74 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2021 | 220 | 0.040 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2000 | 104 | 0.040 |
Why?
|
| Genetic Linkage | 4 | 2005 | 472 | 0.040 |
Why?
|
| DNA Fingerprinting | 2 | 2001 | 108 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2001 | 418 | 0.040 |
Why?
|
| Electrodiagnosis | 1 | 2019 | 10 | 0.040 |
Why?
|
| Loss of Heterozygosity | 3 | 2007 | 124 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2001 | 1005 | 0.040 |
Why?
|
| Cell Cycle Proteins | 3 | 2014 | 703 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2021 | 2483 | 0.040 |
Why?
|
| Macaca mulatta | 2 | 2013 | 496 | 0.040 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 1998 | 19 | 0.040 |
Why?
|
| Sacrum | 1 | 1998 | 28 | 0.040 |
Why?
|
| Mucous Membrane | 1 | 2019 | 88 | 0.040 |
Why?
|
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2018 | 4 | 0.040 |
Why?
|
| Neurons, Afferent | 1 | 1998 | 41 | 0.040 |
Why?
|
| Centromere | 3 | 2005 | 69 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2013 | 600 | 0.040 |
Why?
|
| Neurilemmoma | 1 | 2019 | 42 | 0.040 |
Why?
|
| Genes, Homeobox | 1 | 1998 | 61 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2000 | 251 | 0.040 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2000 | 204 | 0.040 |
Why?
|
| CD11b Antigen | 1 | 2018 | 35 | 0.040 |
Why?
|
| Growth Substances | 1 | 1998 | 102 | 0.040 |
Why?
|
| Bone Diseases | 1 | 1998 | 44 | 0.040 |
Why?
|
| Oocytes | 1 | 2000 | 283 | 0.040 |
Why?
|
| Precancerous Conditions | 1 | 2001 | 283 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 1542 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 999 | 0.040 |
Why?
|
| Spermatozoa | 1 | 2000 | 258 | 0.040 |
Why?
|
| Search Engine | 1 | 2018 | 10 | 0.040 |
Why?
|
| Telomere | 3 | 2008 | 220 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1999 | 191 | 0.030 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2019 | 70 | 0.030 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 1998 | 55 | 0.030 |
Why?
|
| Plasmids | 2 | 1994 | 455 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2012 | 1571 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2001 | 692 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 1998 | 161 | 0.030 |
Why?
|
| Tissue Banks | 1 | 2018 | 29 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 301 | 0.030 |
Why?
|
| Contactin 1 | 1 | 2017 | 4 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2001 | 1008 | 0.030 |
Why?
|
| DNA, Neoplasm | 2 | 2013 | 287 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 381 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 2017 | 78 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2018 | 216 | 0.030 |
Why?
|
| Blotting, Southern | 2 | 1995 | 208 | 0.030 |
Why?
|
| Inflammation | 2 | 2012 | 1493 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2018 | 579 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 2008 | 47 | 0.030 |
Why?
|
| Biological Assay | 1 | 2017 | 108 | 0.030 |
Why?
|
| Glycoproteins | 1 | 1999 | 349 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2017 | 213 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2018 | 161 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2009 | 185 | 0.030 |
Why?
|
| HLA-DQ beta-Chains | 2 | 2007 | 19 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 698 | 0.030 |
Why?
|
| Radiography | 1 | 2019 | 762 | 0.030 |
Why?
|
| Consent Forms | 1 | 2016 | 22 | 0.030 |
Why?
|
| Coroners and Medical Examiners | 1 | 2016 | 15 | 0.030 |
Why?
|
| Germany | 2 | 2009 | 55 | 0.030 |
Why?
|
| RNA | 2 | 2013 | 531 | 0.030 |
Why?
|
| Survival Rate | 1 | 2021 | 2151 | 0.030 |
Why?
|
| Axotomy | 3 | 2001 | 13 | 0.030 |
Why?
|
| Diagnosis | 1 | 2016 | 33 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 384 | 0.030 |
Why?
|
| Vitiligo | 1 | 1996 | 10 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2014 | 3917 | 0.030 |
Why?
|
| Cerebellum | 1 | 2020 | 459 | 0.030 |
Why?
|
| Vitamin K 2 | 1 | 2015 | 6 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 2650 | 0.030 |
Why?
|
| Cell Line | 2 | 2017 | 2606 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2017 | 356 | 0.030 |
Why?
|
| DNA, Recombinant | 2 | 1988 | 71 | 0.030 |
Why?
|
| Confidentiality | 1 | 2016 | 104 | 0.030 |
Why?
|
| Pandemics | 1 | 2023 | 1165 | 0.030 |
Why?
|
| Bacterial Typing Techniques | 1 | 2015 | 101 | 0.030 |
Why?
|
| Bee Venoms | 1 | 2015 | 6 | 0.030 |
Why?
|
| Kidney | 1 | 2022 | 1309 | 0.030 |
Why?
|
| Chemoreceptor Cells | 1 | 2015 | 14 | 0.030 |
Why?
|
| Gene Expression | 2 | 2015 | 1502 | 0.030 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2015 | 25 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2017 | 338 | 0.030 |
Why?
|
| Disclosure | 1 | 2016 | 149 | 0.030 |
Why?
|
| Phospholipids | 1 | 2015 | 103 | 0.030 |
Why?
|
| DNA, Ribosomal | 1 | 1995 | 53 | 0.030 |
Why?
|
| Calcineurin Inhibitors | 1 | 2015 | 22 | 0.030 |
Why?
|
| Electromyography | 1 | 2016 | 141 | 0.030 |
Why?
|
| Receptors, AMPA | 1 | 1995 | 44 | 0.030 |
Why?
|
| IMP Dehydrogenase | 1 | 2015 | 27 | 0.030 |
Why?
|
| Agglutinins | 1 | 1995 | 7 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 1998 | 568 | 0.030 |
Why?
|
| Genes, Bacterial | 1 | 2015 | 217 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2005 | 255 | 0.030 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2014 | 12 | 0.030 |
Why?
|
| Mycophenolic Acid | 1 | 2015 | 61 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2012 | 3451 | 0.030 |
Why?
|
| Sex Chromosomes | 1 | 2014 | 30 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 2016 | 236 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2015 | 200 | 0.030 |
Why?
|
| Opportunistic Infections | 1 | 1995 | 72 | 0.030 |
Why?
|
| Saccharomyces | 1 | 1994 | 9 | 0.030 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2014 | 8 | 0.030 |
Why?
|
| Genome, Mitochondrial | 1 | 2014 | 29 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 2148 | 0.030 |
Why?
|
| Globins | 1 | 1994 | 24 | 0.030 |
Why?
|
| Bacteriophage lambda | 1 | 1994 | 26 | 0.030 |
Why?
|
| Cattle | 1 | 2015 | 521 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2014 | 32 | 0.030 |
Why?
|
| Evoked Potentials, Visual | 1 | 2014 | 33 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2017 | 810 | 0.030 |
Why?
|
| Information Systems | 1 | 1994 | 29 | 0.030 |
Why?
|
| RNA Editing | 1 | 2014 | 32 | 0.030 |
Why?
|
| Nucleotide Motifs | 1 | 2014 | 50 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1994 | 54 | 0.030 |
Why?
|
| X Chromosome | 3 | 2002 | 331 | 0.030 |
Why?
|
| Species Specificity | 1 | 2015 | 519 | 0.030 |
Why?
|
| Transformation, Genetic | 1 | 1994 | 29 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2017 | 832 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2015 | 386 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2015 | 492 | 0.030 |
Why?
|
| Markov Chains | 1 | 1994 | 100 | 0.030 |
Why?
|
| Afferent Pathways | 1 | 2013 | 11 | 0.030 |
Why?
|
| Mechanoreceptors | 1 | 2013 | 12 | 0.030 |
Why?
|
| Hormones | 1 | 2014 | 165 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 1996 | 376 | 0.030 |
Why?
|
| Candidiasis | 1 | 1995 | 132 | 0.030 |
Why?
|
| Proteins | 2 | 2014 | 1027 | 0.030 |
Why?
|
| Proprioception | 1 | 2013 | 17 | 0.030 |
Why?
|
| Riboflavin | 1 | 2013 | 31 | 0.030 |
Why?
|
| Cats | 1 | 2013 | 122 | 0.030 |
Why?
|
| Touch | 1 | 2013 | 39 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 2016 | 399 | 0.030 |
Why?
|
| Carnitine | 1 | 2013 | 72 | 0.020 |
Why?
|
| Apolipoprotein A-V | 1 | 2013 | 23 | 0.020 |
Why?
|
| Algorithms | 2 | 2016 | 1685 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2016 | 495 | 0.020 |
Why?
|
| Leucine | 1 | 2014 | 262 | 0.020 |
Why?
|
| Biomarkers | 1 | 2023 | 3411 | 0.020 |
Why?
|
| Transplant Recipients | 1 | 2015 | 233 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1998 | 1398 | 0.020 |
Why?
|
| Apolipoprotein A-I | 1 | 2013 | 80 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2016 | 8597 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2014 | 418 | 0.020 |
Why?
|
| Vitamins | 1 | 2013 | 115 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 2006 | 436 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2015 | 377 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2013 | 226 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2014 | 322 | 0.020 |
Why?
|
| Proline | 1 | 2013 | 84 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2014 | 235 | 0.020 |
Why?
|
| Recombination, Genetic | 2 | 2006 | 426 | 0.020 |
Why?
|
| Auditory Threshold | 1 | 2012 | 16 | 0.020 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2012 | 24 | 0.020 |
Why?
|
| Surgeons | 1 | 2017 | 287 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2012 | 25 | 0.020 |
Why?
|
| Dogs | 1 | 2013 | 632 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2016 | 400 | 0.020 |
Why?
|
| Systems Biology | 1 | 2012 | 60 | 0.020 |
Why?
|
| Acoustic Stimulation | 1 | 2012 | 83 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 420 | 0.020 |
Why?
|
| Nerve Crush | 2 | 2001 | 8 | 0.020 |
Why?
|
| Arginine | 1 | 2014 | 344 | 0.020 |
Why?
|
| Leukemia | 1 | 1995 | 375 | 0.020 |
Why?
|
| Ligands | 1 | 2013 | 486 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2012 | 199 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2018 | 12997 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 715 | 0.020 |
Why?
|
| Dementia | 1 | 2016 | 434 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2002 | 420 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 570 | 0.020 |
Why?
|
| Minisatellite Repeats | 1 | 2011 | 45 | 0.020 |
Why?
|
| Chromosome Banding | 1 | 2011 | 136 | 0.020 |
Why?
|
| Xenopus Proteins | 1 | 2011 | 59 | 0.020 |
Why?
|
| Genetic Therapy | 1 | 2016 | 726 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2011 | 56 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2011 | 82 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 614 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 955 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 632 | 0.020 |
Why?
|
| DNA Damage | 1 | 1994 | 527 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 664 | 0.020 |
Why?
|
| Amino Acids | 1 | 2013 | 620 | 0.020 |
Why?
|
| Triglycerides | 1 | 2013 | 605 | 0.020 |
Why?
|
| Menkes Kinky Hair Syndrome | 1 | 2010 | 6 | 0.020 |
Why?
|
| Prevalence | 1 | 2017 | 2695 | 0.020 |
Why?
|
| Stem Cells | 1 | 1995 | 713 | 0.020 |
Why?
|
| Liver | 1 | 2018 | 1799 | 0.020 |
Why?
|
| Copper-transporting ATPases | 1 | 2010 | 27 | 0.020 |
Why?
|
| Genome, Fungal | 2 | 2000 | 33 | 0.020 |
Why?
|
| Copper | 1 | 2010 | 74 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2014 | 868 | 0.020 |
Why?
|
| Ontario | 1 | 2009 | 87 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 611 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 2872 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 1405 | 0.020 |
Why?
|
| Locus Control Region | 1 | 2008 | 7 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 609 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 738 | 0.020 |
Why?
|
| Proto-Oncogenes | 1 | 2008 | 36 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2011 | 427 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 810 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 482 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1988 | 73 | 0.020 |
Why?
|
| Growth and Development | 1 | 2008 | 21 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 676 | 0.020 |
Why?
|
| Taste | 1 | 2008 | 28 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2009 | 224 | 0.020 |
Why?
|
| HLA-A24 Antigen | 1 | 2007 | 1 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 2008 | 126 | 0.020 |
Why?
|
| Untranslated Regions | 1 | 2007 | 8 | 0.020 |
Why?
|
| Oogenesis | 1 | 2008 | 52 | 0.020 |
Why?
|
| Insecticides | 1 | 2008 | 47 | 0.020 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2007 | 17 | 0.020 |
Why?
|
| Body Patterning | 1 | 2008 | 128 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 1457 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2008 | 112 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 312 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2008 | 142 | 0.020 |
Why?
|
| Homozygote | 1 | 2009 | 549 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2012 | 1024 | 0.020 |
Why?
|
| Vision, Ocular | 1 | 2008 | 127 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2008 | 439 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2007 | 336 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2009 | 344 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 2006 | 25 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2008 | 249 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 410 | 0.020 |
Why?
|
| RNA Interference | 1 | 2008 | 495 | 0.020 |
Why?
|
| Proteome | 1 | 2008 | 286 | 0.010 |
Why?
|
| HLA-DRB3 Chains | 1 | 2005 | 2 | 0.010 |
Why?
|
| HLA-DQ alpha-Chains | 1 | 2005 | 18 | 0.010 |
Why?
|
| HLA-DRB1 Chains | 1 | 2005 | 47 | 0.010 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2007 | 145 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2009 | 1522 | 0.010 |
Why?
|
| DNA Repair | 1 | 2008 | 577 | 0.010 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2005 | 57 | 0.010 |
Why?
|
| Crossing Over, Genetic | 1 | 2005 | 53 | 0.010 |
Why?
|
| Chromosomes, Human, Y | 1 | 2005 | 51 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 2005 | 163 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 450 | 0.010 |
Why?
|
| Chromosomes, Mammalian | 1 | 2004 | 41 | 0.010 |
Why?
|
| Retroelements | 1 | 2004 | 43 | 0.010 |
Why?
|
| Aorta | 1 | 2007 | 529 | 0.010 |
Why?
|
| Genetics, Medical | 1 | 2005 | 119 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 1395 | 0.010 |
Why?
|
| Switzerland | 1 | 2003 | 15 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2004 | 149 | 0.010 |
Why?
|
| Lod Score | 1 | 2003 | 128 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2006 | 372 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2005 | 274 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2004 | 335 | 0.010 |
Why?
|
| Testis | 1 | 2005 | 413 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2003 | 157 | 0.010 |
Why?
|
| Prosencephalon | 1 | 2002 | 41 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2004 | 241 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2007 | 680 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2005 | 405 | 0.010 |
Why?
|
| Receptor, Notch1 | 1 | 2002 | 75 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 2002 | 38 | 0.010 |
Why?
|
| Fibroblast Growth Factor 5 | 1 | 2001 | 1 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2003 | 328 | 0.010 |
Why?
|
| Wallerian Degeneration | 1 | 2001 | 9 | 0.010 |
Why?
|
| Colforsin | 1 | 2001 | 46 | 0.010 |
Why?
|
| Integrin alpha4 | 1 | 2001 | 12 | 0.010 |
Why?
|
| Paxillin | 1 | 2001 | 13 | 0.010 |
Why?
|
| PC12 Cells | 1 | 2001 | 24 | 0.010 |
Why?
|
| Growth Cones | 1 | 2001 | 15 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 2001 | 67 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 589 | 0.010 |
Why?
|
| Heart | 1 | 2006 | 675 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2002 | 244 | 0.010 |
Why?
|
| Ganglia, Spinal | 1 | 2001 | 64 | 0.010 |
Why?
|
| Marfan Syndrome | 1 | 2003 | 147 | 0.010 |
Why?
|
| Fibronectins | 1 | 2001 | 99 | 0.010 |
Why?
|
| Urine | 1 | 2001 | 92 | 0.010 |
Why?
|
| Sequence Tagged Sites | 1 | 2001 | 27 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 2001 | 87 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2001 | 312 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2002 | 331 | 0.010 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2000 | 11 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2001 | 229 | 0.010 |
Why?
|
| Argonaute Proteins | 1 | 2000 | 29 | 0.010 |
Why?
|
| beta Catenin | 1 | 2001 | 209 | 0.010 |
Why?
|
| Chromosomes, Bacterial | 1 | 2000 | 65 | 0.010 |
Why?
|
| Helminth Proteins | 1 | 2000 | 104 | 0.010 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 1999 | 16 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2002 | 567 | 0.010 |
Why?
|
| Spermatogenesis | 1 | 2000 | 171 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1982 | 652 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1999 | 110 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 2299 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 694 | 0.010 |
Why?
|
| Receptors, Notch | 1 | 2000 | 204 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1998 | 236 | 0.010 |
Why?
|
| Research Design | 1 | 2002 | 723 | 0.010 |
Why?
|
| Risk Factors | 1 | 2013 | 10965 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1998 | 147 | 0.010 |
Why?
|
| Histones | 1 | 2002 | 533 | 0.010 |
Why?
|
| Comorbidity | 1 | 2003 | 1600 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2001 | 1316 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1998 | 452 | 0.010 |
Why?
|
| Gene Library | 1 | 1998 | 213 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2001 | 781 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 1998 | 231 | 0.010 |
Why?
|
| Echocardiography | 1 | 2003 | 1138 | 0.010 |
Why?
|
| Antibodies | 1 | 1998 | 358 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1998 | 293 | 0.010 |
Why?
|
| Models, Genetic | 1 | 1999 | 752 | 0.010 |
Why?
|
| Receptors, Glutamate | 1 | 1995 | 18 | 0.010 |
Why?
|
| Mating Factor | 1 | 1995 | 5 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2000 | 780 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2001 | 4682 | 0.000 |
Why?
|